109 related articles for article (PubMed ID: 11907935)
1. Pharmacokinetic comparison between Conpremin (Premarin) and a generic preparation of conjugated estrogens.
Arteaga E; Villaseca P
Climacteric; 1998 Dec; 1(4):284-9. PubMed ID: 11907935
[TBL] [Abstract][Full Text] [Related]
2. Comparison of pharmacokinetics of a conjugated equine estrogen preparation (premarin) and a synthetic mixture of estrogens (C.E.S.) in postmenopausal women.
Bhavnani BR; Nisker JA; Martin J; Aletebi F; Watson L; Milne JK
J Soc Gynecol Investig; 2000; 7(3):175-83. PubMed ID: 10865186
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of single- and multiple-dose pharmacokinetics of synthetic conjugated estrogens, A (Cenestin) tablets: a slow-release estrogen replacement product.
Stevens RE; Roy R; Phelps KV
J Clin Pharmacol; 2002 Mar; 42(3):332-41. PubMed ID: 11865971
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of equilin sulfate in the dog.
Chandrasekaran A; Osman M; Scatina JA; Sisenwine SF
J Steroid Biochem Mol Biol; 1995 Nov; 55(2):271-8. PubMed ID: 7495708
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism.
Bhavnani BR
Proc Soc Exp Biol Med; 1998 Jan; 217(1):6-16. PubMed ID: 9421201
[TBL] [Abstract][Full Text] [Related]
6. A randomized, multiple-dose parallel study to compare the pharmacokinetic parameters of synthetic conjugated estrogens, A, administered as oral tablet or vaginal cream.
Bhamra RK; Margolis MB; Liu JH; Hendy CH; Jenkins RG; DiLiberti CE
Menopause; 2011 Apr; 18(4):393-9. PubMed ID: 21107298
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of 17 beta-dihydroequilin sulfate and 17 beta-dihydroequilin in normal postmenopausal women.
Bhavnani BR; Cecutti A
J Clin Endocrinol Metab; 1994 Jan; 78(1):197-204. PubMed ID: 8288704
[TBL] [Abstract][Full Text] [Related]
8. Steady-state pharmacokinetics of conjugated equine estrogens in healthy, postmenopausal women.
Mayer P; Tse S; Sendi M; Bourg D; Morrison D
J Reprod Med; 2008 Feb; 53(2):97-101. PubMed ID: 18357800
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of a novel estrogen delta8-estrone in postmenopausal women and men.
Bhavnani BR; Cecutti A; Gerulath A
J Steroid Biochem Mol Biol; 1998 Oct; 67(2):119-31. PubMed ID: 9877212
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of 17 beta-dihydroequilin sulfate in normal postmenopausal women under steady state conditions.
Bhavnani BR; Cecutti A; Gerulath A
J Soc Gynecol Investig; 2002; 9(2):102-10. PubMed ID: 12398033
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic Study of Conjugated Equine Estrogens in Healthy Chinese Postmenopausal Women Using a Parallel Two-Column LC-MS/MS Method.
Shi M; Yin L; Sun Y; Wang C; Cai L; Zhang T; Zhou X; Fawcett JP; Gao X; Gu J
Clin Pharmacokinet; 2022 Nov; 61(11):1571-1583. PubMed ID: 36173592
[TBL] [Abstract][Full Text] [Related]
12. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
[TBL] [Abstract][Full Text] [Related]
13. Metabolic clearance rate of equilin sulfate and its conversion to plasma equilin, conjugated and unconjugated equilenin, 17 beta-dihydroequilin, and 17 beta-dihydroequilenin in normal postmenopausal women and men under steady state conditions.
Bhavnani BR; Cecutti A
J Clin Endocrinol Metab; 1993 Nov; 77(5):1269-74. PubMed ID: 8077320
[TBL] [Abstract][Full Text] [Related]
14. Serum equilin, oestrone, and oestradiol levels in postmenopausal women receiving conjugated equine oestrogens ('Premarin').
Whittaker PG; Morgan MR; Dean PD; Cameron EH; Lind T
Lancet; 1980 Jan; 1(8158):14-6. PubMed ID: 6101354
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoassay of plasma equilin and estrone in postmenopausal women after the administration of premarin.
Bhavnani BR; Sarda IR; Woolever CA
J Clin Endocrinol Metab; 1981 Apr; 52(4):741-7. PubMed ID: 6259193
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of orally administered estradiol valerate. Results of a single-dose cross-over bioequivalence study in postmenopausal women.
Zimmermann H; Koytchev R; Mayer O; Börner A; Mellinger U; Breitbarth H
Arzneimittelforschung; 1998 Sep; 48(9):941-7. PubMed ID: 9793623
[TBL] [Abstract][Full Text] [Related]
17. Conjugated estrogens bioinequivalence: comparison of four products in postmenopausal women.
Adams WP; Hasegawa J; Johnson RN; Haring RC
J Pharm Sci; 1979 Aug; 68(8):986-91. PubMed ID: 225466
[TBL] [Abstract][Full Text] [Related]
18. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
Zhao L; Brinton RD
BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
[TBL] [Abstract][Full Text] [Related]
19. Transport of equine estrogens: binding of conjugated and unconjugated equine estrogens with human serum proteins.
Pan CC; Woolever CA; Bhavnani BR
J Clin Endocrinol Metab; 1985 Sep; 61(3):499-507. PubMed ID: 4040531
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of a modified-release estrogen tablet.
Bhamra R; Kaercher U; Oleary CM
J Reprod Med; 2010; 55(9-10):404-10. PubMed ID: 21043366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
